Ειδοποίηση Μελετητή:[ ΣΤΟΜΑΤΙΤΙΣ ]
Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy
K Momo, H Nagaoka, Y Kizawa, H Bukawa, S Chiba… - Supportive Care in Cancer, 2017
... Jpn J Clin Res Death Dying 23: 98–103 9. Nakamura T, Aoyama T, Yanagihara Y et al (2003)
The effects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic
stem cell transplantation. Yakugaku Zasshi 123: 1023–1029 10. ...
The effects of indomethacin spray on the pain of stomatitis in the patients for hematopoietic
stem cell transplantation. Yakugaku Zasshi 123: 1023–1029 10. ...
 |  |  |
Болезнь Бехчета: внутрисердечный тромбоз (описание двух наблюдений и обзор литературы)
ЗС Алекберова, ПС Овчаров, ТА Лисицына… - Терапевтический архив, 2017
... Behçet's disease (BD) is systemic vasculitis of unknown etiology, which is more common in the
countries located along the Great Silk Road. The disease is diagnosed if a patient has 4 key
diagnostic signs: aphthous stomatitis, genital sores, and eye and skin lesions. ...
countries located along the Great Silk Road. The disease is diagnosed if a patient has 4 key
diagnostic signs: aphthous stomatitis, genital sores, and eye and skin lesions. ...
| | |
Functionalized 2D nanomaterials for gene delivery applications
F Yin, B Gu, Y Lin, N Panwar, SC Tjin, J Qu, SP Lau… - Coordination Chemistry …, 2017
During the last decade, two-dimensional (2D) nanomaterials have attracted tremendous
interest in many different fields, including electrochemistry, energy stora.
interest in many different fields, including electrochemistry, energy stora.
| | |
[HTML] Ozonoterapia en la estomatitis subprótesis, 2016
YM Sosa, YLT Velázquez, RMV Zamora, MR Tamayo - MULTIMED Revista Médica …, 2017
... Ozonoterapia en la estomatitis subprótesis, 2016. Ozone therapy in subprosthesis stomatitis,
2016. MsC. At. Urg. Estomatol. ... The result was: 67.33 % of the patients were affected by stomatitis
grade II subprosthesis, 60-69 years was the most affected age group (41.09 %). ...
2016. MsC. At. Urg. Estomatol. ... The result was: 67.33 % of the patients were affected by stomatitis
grade II subprosthesis, 60-69 years was the most affected age group (41.09 %). ...
| | |
[HTML] Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey
KL Irwin, MF Jalloh, J Corker, BA Mahmoud… - Vaccine, 2017
... At this time, phase 3 clinical trials of an experimental Ebola vaccine (recombinant vesicular
stomatitis virus vaccine [rVSV-ZEBOV]) were underway in Guinea and neighboring Sierra Leone
[7] ; [8]. The Guinean investigators spread information about the trial in the Maritime ...
stomatitis virus vaccine [rVSV-ZEBOV]) were underway in Guinea and neighboring Sierra Leone
[7] ; [8]. The Guinean investigators spread information about the trial in the Maritime ...
| | |
Panitumumab Approved for Use in Wild-Type RAS Metastatic Colorectal Cancer
C Nalley - Oncology Times, 2017
... Most common adverse reactions (≥ 20%) with panitumumab plus FOLFOX are diarrhea,
stomatitis, mucosal inflammation, asthenia, paronychia, anorexia, hypomagnesemia,
hypokalemia, rash, acneiform dermatitis, pruritus, and dry skin. ...
stomatitis, mucosal inflammation, asthenia, paronychia, anorexia, hypomagnesemia,
hypokalemia, rash, acneiform dermatitis, pruritus, and dry skin. ...
| | |
Oral Disease and Microbiota in Free-roaming cats
A Whyte, A Gracia, C Bonastre, MT Tejedor, J Whyte… - Topics in Companion …, 2017
Oral health status was evaluated in thirty-four free-roaming cats that were submitted to a
Trap-Neuter-Return program. Only 38.2% of individual cats showed oral.
Trap-Neuter-Return program. Only 38.2% of individual cats showed oral.
| | |
A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic …
SR Park, MJ Kim, BH Nam, CG Kim, JY Lee, SJ Cho… - European Journal of Cancer, 2017
... Vomiting, 0 (0%), 3 (5.1%), 3 (5.1%), 2 (3.2%), 0 (0%), 4 (6.5%). Diarrhoea, 1 (1.7%), 2 (3.4%),
3 (5.1%), 4 (6.5%), 2 (4.4%), 7 (11.3%). Stomatitis, 1 (1.7%), 0 (0%), 1 (1.7%), 0 (0%), 1 (2.2%),
1 (1.6%). Constipation, 0 (0%), 0 (0%), 0 (0%), 0 (0%), 0 (0%), 0 (0%). ...
3 (5.1%), 4 (6.5%), 2 (4.4%), 7 (11.3%). Stomatitis, 1 (1.7%), 0 (0%), 1 (1.7%), 0 (0%), 1 (2.2%),
1 (1.6%). Constipation, 0 (0%), 0 (0%), 0 (0%), 0 (0%), 0 (0%), 0 (0%). ...
| | |
[HTML] Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
O Hamid, B Hoffner, E Gasal, J Hong, RD Carvajal - Cancer Immunology, …, 2017
... Solid tumors NCT01598129 1 RN A viruses MG1MA3 Rhabdo virus MA GE-A3 MG1MA3 Solid
tumors NCT02285816 1/2 VSV -IFN-beta V esicular stomatitis virus IFN-β VSV -IFN-beta HCC
NCT01628640 1 Reolysin Reo virus None (wild-type) Reolysin + carboplatin + paclitax ...
tumors NCT02285816 1/2 VSV -IFN-beta V esicular stomatitis virus IFN-β VSV -IFN-beta HCC
NCT01628640 1 Reolysin Reo virus None (wild-type) Reolysin + carboplatin + paclitax ...
| | |
Textbook of Prosthodontics-E Book
V Rangarajan, TV Padmanabhan - 2017
| | |
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου